CJC-1295 vs Hexarelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Hexarelin

Hexarelin is a potent synthetic hexapeptide growth hormone secretagogue. It provides the strongest GH release among GHRPs but is associated with rapid desensitization of receptors.

Full details →

Side-by-Side Comparison

Aspect	CJC-1295	Hexarelin
Dose Range	1 mg–2 mg	100 mcg–300 mcg
Frequency	Less than daily	2x daily
Cycle Length	8–12 weeks	8–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.	Acts as a ghrelin mimetic with high potency at the GHS receptor. Provides powerful GH release but receptor desensitization occurs faster than with other GHRPs, requiring cycling.
Typical Dosage	CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.	Typical dosing: 100-200mcg administered 2-3 times daily for 4-6 weeks, followed by an equal off period to allow receptor resensitization.
Administration	Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.	Subcutaneous injection. Cycling is essential to maintain effectiveness. Often used in short bursts rather than continuous protocols.
Side Effects	Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.	Water retention, cortisol and prolactin increase, hunger (moderate), tingling, and potential blood pressure effects.
Best For	Muscle Growth Fat Loss Sleep Quality	Muscle Growth Recovery & Healing